MicroRNAs in allergy and asthma

Current Allergy and Asthma Reports

Volumn 14, Issue 4, 2014, Pages

  Rebane, Ana ^a   Akdis, Cezmi A ^b,c  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c CHRISTINE KÜHNE CENTER FOR ALLERGY RESEARCH AND EDUCATION CK CARE   (Switzerland)

Author keywords

Allergy; Asthma; Atopic; Dendritic cells; Epithelial cells; Extracellular miRNA; microRNA; Non coding RNA; T cells

Indexed keywords

AQUAPORIN 4; ARGONAUTE 2 PROTEIN; BIOLOGICAL MARKER; CORTICOSTEROID; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MICRORNA; MICRORNA 1; MICRORNA 106A; MICRORNA 122; MICRORNA 125B; MICRORNA 126; MICRORNA 146A; MICRORNA 146B; MICRORNA 150; MICRORNA 155; MICRORNA 21; MICRORNA 221; MICRORNA 375; MICRORNA 7; MIRAVIRSEN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADAPTIVE IMMUNITY; ALLERGIC TISSUE INFLAMMATION; ALLERGY; APOPTOSIS; ASTHMA; ATOPIC DERMATITIS; AUTOIMMUNITY; BIOGENESIS; CD8+ T LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CHRONIC INFLAMMATION; CHRONIC RHINOSINUSITIS; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EXOSOME; GENE SILENCING; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN PRODUCTION; IMMUNOREGULATION; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LUNG PARENCHYMA; MEMORY CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PNEUMONIA; POLARIZATION; PROTEIN EXPRESSION; REVIEW; RNA ANALYSIS; RNA PROCESSING; RNA SEQUENCE; SKIN ALLERGY; TH1 CELL; TH1 TH2 BALANCE; TH17 CELL; TH2 CELL; TISSUE INJURY; TISSUE REACTION; VIRUS REPLICATION; ANIMAL; HYPERSENSITIVITY; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ASTHMA; HUMANS; HYPERSENSITIVITY; MICRORNAS;

EID: 84893156260     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-014-0424-x     Document Type: Review

References (101)

1. Makeyev EV, Maniatis T. Multilevel regulation of gene expression by microRNAs. Science. 2008;319(5871):1789-90. (Pubitemid 351451555)
2. Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs. Science. 2011;331(6017):550-3.
3. Agache I et al. Untangling asthma phenotypes and endotypes. Allergy. 2012;67(7):835-46.
4. Lotvall J et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355-60.
5. Rebane A, Akdis CA. MicroRNAs: Essential players in the regulation of inflammation. J Allergy Clin Immunol. 2013;132(1):15-26.
6. Lu TX, Rothenberg ME. Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases. J Allergy Clin Immunol. 2013;132(1):3-13. quiz 14.
7. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 2010;11(9):597-610.
8. Winter J et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009;11(3):228-34.
9. Gu S et al. Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs. Nat Struct Mol Biol. 2009;16(2):144-50.
10. Medzhitov R. Inflammation 2010: new adventures of an old flame. Cell. 2010;140(6):771-6.
11. Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol. 2012;12(1):9-23.
12. Akdis CA. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med. 2012;18(5):736-49.
13. Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011;8(5):706-13.
14. Iliopoulos D et al. STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol Cell. 2010;39(4):493-506.
15. Sheedy FJ et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010;11(2):141-7.
16. Taganov KD et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481-6. (Pubitemid 44267285)
17. Etzrodt M et al. Regulation of monocyte functional heterogeneity by miR-146a and Relb. Cell Rep. 2012;1(4):317-24.
18. Crone SG et al. microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer. 2012;11:71.
19. Zhao JL et al. NF-{kappa}B dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc Natl Acad Sci U S A. 2011;108(22):9184-9.
20. Boldin MP et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med. 2011;208(6):1189-201.
21. Lu LF et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell. 2010;142(6):914-29.
22. Guo Q et al. Forced miR-146a expression causes autoimmune lymphoproliferative syndrome in mice via downregulation of Fas in germinal center B cells. Blood. 2013;121(24):4875-83.
23. Wang P et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol. 2010;185(10):6226-33.
24. O'Connell RM et al. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A. 2009;106(17):7113-8.
25. Nazari-Jahantigh M et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122(11):4190-202.
26. Rodriguez A et al. Requirement of bic/microRNA-155 for normal immune function. Science. 2007;316(5824):608-11. (Pubitemid 46683148)
27. O'Connell RM et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33(4):607-19.
28. Boldin MP, Baltimore D. MicroRNAs, new effectors and regulators of NF-kappaB. Immunol Rev. 2012;246(1):205-20.
29. Baumjohann D, Ansel KM. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol. 2013;13(9):666-78.
30. de Yebenes VG, Bartolome-Izquierdo N, Ramiro AR. Regulation of B-cell development and function by microRNAs. Immunol Rev. 2013;253(1):25-39.
31. Feng MJ et al. MicroRNA-181a, -146a and -146b in spleen CD4+ T lymphocytes play proinflammatory roles in a murine model of asthma. Int Immunopharmacol. 2012;13(3):347-53.
32. • Malmhall, C., et al., MicroRNA-155 is essential for T2-mediated allergen-induced eosinophilic inflammation in the lung. J Allergy Clin Immunol, 2013. This paper demonstrates reduced Th2 type inflammation in OVA-induced mouse model of asthma in miR-155-deficient mice.
33. Mattes J et al. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci U S A. 2009;106(44):18704-9.
34. Collison A et al. Altered expression of microRNA in the airway wall in chronic asthma: miR-126 as a potential therapeutic target. BMC Pulm Med. 2011;11:29.
35. Collison A et al. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011;128(1):160-167 e4.
36. Sharma A et al. Antagonism of mmu-mir-106a attenuates asthma features in allergic murine model. J Appl Physiol. 2012;113(3):459-64.
37. Qin HB et al. Inhibition of miRNA-221 Suppresses the Airway Inflammation in Asthma. Inflammation. 2012;35(4):1595-9.
38. Montagner S et al. The role of miRNAs in mast cells and other innate immune cells. Immunol Rev. 2013;253(1):12-24.
39. Mayoral RJ et al. MicroRNA-221-222 regulate the cell cycle in mast cells. J Immunol. 2009;182(1):433-45.
40. Akdis M, et al. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2011;127(3):701-21.e1-70.
41. Lu TX, Munitz A, Rothenberg ME. MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. J Immunol. 2009;182(8):4994-5002.
42. Lu TX et al. MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-gamma pathway, Th1 polarization, and the severity of delayed-type hypersensitivity. J Immunol. 2011;187(6):3362-73.
43. Case SR et al. MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp Lung Res. 2011;37(8):500-8.
44. Chen RF et al. MicroRNA-21 expression in neonatal blood associated with antenatal immunoglobulin E production and development of allergic rhinitis. Clin Exp Allergy. 2010;40(10):1482-90.
45. • Lu, T.X., et al., MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol. 2012;129(4):1064-75 e9. This study demonstrates the differential expression of miR-146a, miR-146b and miR-223 esophageal tissue and in plasma from EoE patients, which suggests that extracellular miRNAs could be used as potential biomarkers of allergic diseases.
46. Lu TX et al. MiR-375 is downregulated in epithelial cells after IL-13 stimulation and regulates an IL-13-induced epithelial transcriptome. Mucosal Immunol. 2012;5(4):388-96.
47. Vennegaard MT et al. Allergic contact dermatitis induces upregulation of identical microRNAs in humans and mice. Contact Dermatitis. 2012;67(5):298-305.
48. Kumar, M., et al., Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol. 2011.
49. Polikepahad S et al. Proinflammatory role for let-7 microRNAS in experimental asthma. J Biol Chem. 2010;285(39):30139-49.
50. Martinez-Nunez RT, Louafi F, Sanchez-Elsner T. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem. 2011;286(3):1786-94.
51. • Biton, M., et al., Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol. 2011;12(3):239-46. This study demonstrates that miR-375 promotes the expression of TSLP and the differentiation of Th2 cells in gut mucosal epithelial cells.
52. Bleck B et al. MicroRNA-375 regulation of thymic stromal lymphopoietin by diesel exhaust particles and ambient particulate matter in human bronchial epithelial cells. J Immunol. 2013;190(7):3757-63.
53. Rossato M et al. IL-10-induced microRNA-187 negatively regulates TNF-alpha, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc Natl Acad Sci U S A. 2012;109(45):E3101-10.
54. Trotta R et al. miR-155 regulates IFN-gamma production in natural killer cells. Blood. 2012;119(15):3478-85.
55. Trotta R et al. Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells. Blood. 2013;121(16):3126-34.
56. Williams AE et al. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS One. 2009;4(6):e5889.
57. Jardim MJ et al. Distinct microRNA expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. Am J Respir Cell Mol Biol. 2012;47(4):536-42.
58. Perry MM et al. Rapid changes in microRNA-146a expression negatively regulate the IL-1beta-induced inflammatory response in human lung alveolar epithelial cells. J Immunol. 2008;180(8):5689-98.
59. Liu X et al. MicroRNA-146a modulates human bronchial epithelial cell survival in response to the cytokine-induced apoptosis. Biochem Biophys Res Commun. 2009;380(1):177-82.
60. Takyar S et al. VEGF controls lung Th2 inflammation via the miR-1-Mpl (myeloproliferative leukemia virus oncogene)-P-selectin axis. J Exp Med. 2013;210(10):1993-2010.
61. Chiba Y, Misawa M. MicroRNAs and their therapeutic potential for human diseases: MiR-133a and bronchial smooth muscle hyperresponsiveness in asthma. J Pharmacol Sci. 2010;114(3):264-8.
62. Jude JA et al. miR-140-3p regulation of TNF-alpha-induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2012;303(5):L460-8.
63. Sonkoly E, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol. 2010;126(3):581-9.e1- 20.
64. Akdis M et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199(11):1567-75. (Pubitemid 38780411)
65. Sonkoly E et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007;2(7):e610.
66. Xu N et al. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. J Invest Dermatol. 2011;131(7):1521-9.
67. Rebane A et al. Mechanisms of IFN-gamma-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. J Allergy Clin Immunol. 2012;129(5):1297-306.
68. Zhang XH et al. Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med. 2012;185(2):140-51.
69. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716-25.
70. Mitchell PS et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513-8.
71. Hanke M et al. A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer. Urol Oncol. 2010;28(6):655-61.
72. Park NJ et al. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res. 2009;15(17):5473-7.
73. Cortez MA et al. MicroRNAs in body fluids-the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467-77.
74. Weiland M et al. Small RNAs have a large impact: Circulating microRNAs as biomarkers for human diseases. RNA Biol. 2012;9(6):850-9.
75. Roberts TC et al. Extracellular microRNAs are dynamic nonvesicular biomarkers of muscle turnover. Nucleic Acids Res. 2013;41(20):9500-13.
76. Akbas F et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res. 2012;38(6):286-94.
77. Levanen B et al. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J Allergy Clin Immunol. 2013;131(3):894-903.
78. Sinha A et al. Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases. J Allergy Clin Immunol. 2013;132(1):219-22.
79. Redis RS et al. Cell-to-cell miRNA transfer: From body homeostasis to therapy. Pharmacol Ther. 2012;136(2):169-74.
80. Vickers KC et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13(4):423-33.
81. Arroyo JD et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108(12):5003-8.
82. Turchinovich A et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39(16):7223-33.
83. Li L et al. Argonaute 2 Complexes Selectively Protect the Circulating MicroRNAs in Cell-Secreted Microvesicles. PLoS One. 2012;7(10):e46957.
84. • Bryniarski, K., et al., Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector Tcells to inhibit contact sensitivity. J Allergy Clin Immunol. 2013; 132 (1):170-81. This study demonstrates that the nanovesicles containing miR-150 are capable of entering into effector T cells and suppress ACD, and they promoted antigen-specific tolerance in mice.
85. Robinson, DS. The role of the T cell in asthma. J Allergy Clin Immunol. 2010;126(6):1081-91; quiz 1092-3.
86. Klunker S et al. A second step of chemotaxis after transendothelial migration: keratinocytes undergoing apoptosis release IFN-gamma-inducible protein 10, monokine induced by IFN-gamma, and IFN-gamma-inducible alpha-chemoattractant for T cell chemotaxis toward epidermis in atopic dermatitis. J Immunol. 2003;171(2):1078-84. (Pubitemid 36871425)
87. Soyka MB et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol. 2012;130(5):1087-1096 e10.
88. Akdis M, et al. TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol. 2012;129(6):1438-49; quiz1450-1.
89. Eyerich S et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009;119(12):3573-85.
90. Holtzman MJ. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 2012;122(8):2741-8.
91. Salimi M et al. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med. 2013;210(13):2939-50.
92. Deniz G, van de Veen W, Akdis M. Natural killer cells in patients with allergic diseases. J Allergy Clin Immunol. 2013;132(3):527-35.
93. Nadif R et al. The role of eosinophils and basophils in allergic diseases considering genetic findings. Curr Opin Allergy Clin Immunol. 2013;13(5):507-13.
94. Soyka MB, Holzmann D, Akdis CA. Regulatory cells in allergen-specific immunotherapy. Immunotherapy. 2012;4(4):389-96.
95. Licona-Limon P et al. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol. 2013;14(6):536-42.
96. Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov. 2009;8(8):645-60.
97. Kanasty RL et al. Action and reaction: the biological response to siRNA and its delivery vehicles. Mol Ther. 2012;20(3):513-24.
98. Lanford RE et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327(5962):198-201.
99. Bader AG. miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet. 2012;3:120.
100. Ling H, Fabbri M, Calin GA. MicroRNAs and other non-coding RNAs as targets for anticancer drug development. Nat Rev Drug Discov. 2013;12(11):847-65.
101. Tsitsiou E et al. Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma. J Allergy Clin Immunol. 2012;129(1):95-103.